Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Plasmology4
AddedFeb 16, 2024
UpdatedJun 18, 2026
Plasmology4

Plasmology4

Angel

US-based Cold Plasma Medical Technologies, Inc., founded in 2010, develops innovative medical devices.

HQ
Scottsdale, AZ, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Plasmology4, originally incorporated as Cold Plasma Medical Technologies, Inc. in 2010 and based in Phoenix, Arizona, is dedicated to developing innovative medical devices. The company's core mission is to harness the fourth state of matter—plasma—to improve patient outcomes globally. Their flagship platform, Plaz4®, offers groundbreaking applications aimed at treating multidrug-refractory bacteria and other medical challenges. Plasmology4 focuses on leveraging advanced plasma technology to address critical healthcare needs, positioning itself at the forefront of medical innovation.

Notable achievements include receiving the FDA's "Breakthrough Device Designation" for their Plaz4® technology, underscoring its potential impact on treating severe bacterial infections. The company has attracted attention from key investors and industry experts due to its pioneering approach and promising results. Plasmology4's advancements in plasma technology have the potential to revolutionize medical treatments, significantly enhancing the quality of life for patients worldwide.

Plasmology4 - Similar Companies

Aaplasma logo

Aaplasma

aaplasma.com

US Medical Innovations logo

US Medical Innovations

Atmospheric Plasma Solutions logo

Atmospheric Plasma Solutions

Plasmonix logo

Plasmonix

Plasmonic Diagnostics logo

Plasmonic Diagnostics

WildSpark Technologies logo

WildSpark Technologies

Tiumed logo

Tiumed

Sterionics logo

Sterionics

sterionics.com

FreMon Scientific logo

FreMon Scientific

CryoMedix logo

CryoMedix

cryomedix.com

Origin logo

Origin

originww.com

Scion Plasma logo

Scion Plasma

scionplasma.com

Plastomics logo

Plastomics

plastomics.com

Transient Plasma Systems logo

Transient Plasma Systems

Zenith Technical Innovations logo

Zenith Technical Innovations

Plasmology4 - Quick Facts

Who are Plasmology4's competitors?

Companies similar to Plasmology4 include Aaplasma, US Medical Innovations, Atmospheric Plasma Solutions and Plasmonix.

When was Plasmology4 founded?

Plasmology4 was founded in 2010.

Where is Plasmology4's headquarters located?

Plasmology4's headquarters is located in Scottsdale, AZ, US.

When was Plasmology4's last funding round?

Plasmology4's most recent funding round was for $250k (USD) in December 2016.

How much has Plasmology4 raised to-date?

As of Dec 14, 2016, Plasmology4 has raised a total of $4.3M (USD).

How many employees does Plasmology4 have?

Plasmology4 has 5 employees as of Feb 5, 2024.

Plasmology4 - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Plasma
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Biotech
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified